When Tissue is an Issue the Liquid Biopsy is Nonissue: A Review

Fecha de publicación: Fecha Ahead of Print:

Autores organización

Autores

  • Rodríguez, J
  • Avila, J
  • Rolfo, C
  • Ruíz-Patiño, A
  • Russo, A
  • Ricaurte, L
  • Ordóñez-Reyes, C
  • Arrieta, O
  • Zatarain-Barrón, ZL
  • Recondo, G

Grupos de investigación

Resumen

Precision medicine has impacted the field of medical oncology by introducing personalized therapies, improving all measurable outcomes. This field, in turn, has expanded to obtaining and analyzing a vast and ever-increasing amount of genomic information. One technique currently applied is the liquid biopsy, which consists of detecting and isolating DNA and exosomes in cancer patients. Newly developed techniques have made it possible to use the liquid biopsy in a wide range of settings. However, challenges regarding the validation of its clinical utility exist because of a lack of standardization across different techniques and tumor types, confounder genomic information, lack of appropriate clinical trial designs, and a non-measured, and therefore not estimated, economic impact on population health. Nowadays, liquid biopsy is not routinely used, but ongoing research is increasing its popularity, and a new era in oncology is developing. Therefore, it is essential to have an in-depth understanding of the liquid biopsy technique. In this review, we summarize the leading techniques and liquid biopsy applications in cancer.

Datos de la publicación

ISSN/ISSNe:
2366-1070, 2366-1089

Oncology And Therapy  SPRINGER

Tipo:
Review
Páginas:
89-110

Citas Recibidas en Web of Science: 28

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Cell-free DNA; Circulating tumor cells; Diagnosis; Liquid biopsy; Screening

Campos de estudio

Citar la publicación

Compartir la publicación